Long Term Follow-Up
Jul 28, 2022•21 min
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
Several recent large trials just released long term follow-up results on overall survival. We look at what how treatment principles may change based on these mature data.
ECHELON-1 - Hodgkin's (A+AVD vs. ABVD)
POLO - Pancreatic (olaparib maintenance vs. placebo)
Keynote 355 - mTNBC (pembrolizumab + chemo vs. chemo)
APHinity - adjuvant HER+ breast (pertuzumab/trastuzumab vs. trastuzumab)
E1912 - CLL (ibrutinib/rituximab vs. FCR)
For the best experience, listen in Metacast app for iOS or Android